Balaxi Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹73.27Cr
Net Profits
₹4.59Cr
Net Profit Margins
6.26%
Highlights
Revenue:

Balaxi Pharmaceuticals Ltd’s revenue jumped 20.81% since last year same period to ₹73.27Cr in the Q2 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 14.9% jump in its revenue since last 3-months.

Net Profits:

Balaxi Pharmaceuticals Ltd’s net profit fell -68.19% since last year same period to ₹4.59Cr in the Q2 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -29.17% fall in its net profits since last 3-months.

Net Profit Margins:

Balaxi Pharmaceuticals Ltd’s net profit margin fell -73.67% since last year same period to 6.26% in the Q2 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -38.35% fall in its net profit margins since last 3-months.

FAQs

The revenue for Balaxi Pharmaceuticals Ltd in the Q2 results 2024 was ₹73.27Cr.

The net profit for Balaxi Pharmaceuticals Ltd in the Q2 results 2024 was ₹4.59Cr.

The net profit margin for Balaxi Pharmaceuticals Ltd in the Q2 results 2024 was 6.26%.

The revenue for Balaxi Pharmaceuticals Ltd in the Q2 results 2023 was ₹60.65Cr.

The net profit for Balaxi Pharmaceuticals Ltd in the Q2 results 2023 was ₹14.43Cr.

The net profit margin for Balaxi Pharmaceuticals Ltd in the Q2 results 2023 was 23.79%.